NCT03528525 is a clinical trial in Monogenic Diseases, sponsored by Kunling Shen.

Who is sponsoring NCT03528525?

NCT03528525 is sponsored by Kunling Shen.

What condition does NCT03528525 study?

NCT03528525 studies Monogenic Diseases.

Is NCT03528525 still recruiting?

NCT03528525 is currently recruiting now. Last updated 18 May 2018.

Last reviewed 2018-05-18 · How we verify

NCT03528525

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Registry Study on Respiratory Monogenic Diseases in Chinese Children

Recruiting now Last updated 18 May 2018

What this trial tests

trial in Monogenic Diseases in 200 participants. Currently enrolling.

Timeline

1 January 2017

Primary endpoint
1 January 2018

30 December 2030

Quick facts

Lead sponsor	Kunling Shen
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	200
Start date	1 January 2017
Primary completion	1 January 2018
Estimated completion	30 December 2030
Sites	1 location across China

Conditions studied

Monogenic Diseases — all drugs for Monogenic Diseases →

Sponsor

Kunling Shen

Who can join

Adults 1 Month to 18, any sex, with Monogenic Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a multicenter, prospective cohort study of patients diagnosed with respiratory monogenic diseases, the clinical information of recruited patients, including clinical manifestations, lung function, chest imaging, quality of life and other indicators, will be followed for 5 years.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03528525 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kunling Shen
Last refreshed: 18 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03528525.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing